Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008
- PMID: 21301223
- DOI: 10.4161/hv.7.0.14613
Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008
Abstract
Prevention and control of adverse events following immunization (AEFI) are fundamental activities of successful immunisation programs. AEFI reporting, investigation and analysis, integrated by consultancy for subjects needing a specialized evaluation, represent an ideal model for vaccine safety surveillance. In the Veneto Region of Italy the Green Channel Centre has been created by the local Public Health authority, to offer a consultancy activity for vaccinations at risk of adverse events and to ensure an efficient AEFI surveillance system with regular feedback data for vaccine personnel. This report updates the overall activity provided by the Green Channel between 1992 and 2008, concerning consultations for previous AEFI and contraindications to vaccinations and analysis of AEFI reports. After 1280 consultancy cases, 998 (78%) subjects were found eligible for vaccination, with personalized precautions suggested in 42% of cases. Of a total of 724 patients actually vaccinated as per the Green Channel instructions, only 55 subjects (7.6%) reported mild symptoms and one (0.3%) a moderate allergic reaction. Since 1993, a total of 5,006 AEFI reports have been collected and evaluated by the Green Channel against more than 20 millions of vaccine doses administered with an estimate mean AEFI rate of 2.3 x 10.000 doses per year. The majority of them (94%) were found in causal relationship with vaccines; of these, 267 reports (5,6% - 0.1/10,000 doses) were serious and 9 of these subjects, affected by a neurological event, were not recovered or were still on therapy at follow up. This regional activity has proven efficacious in evaluating and managing individual cases at potential risk of AEFI and integrating the national passive surveillance system.
Similar articles
-
Vaccine allergy evaluation and management at the specialized Green Channel Consultation Clinic.Clin Exp Allergy. 2012 Jul;42(7):1088-96. doi: 10.1111/j.1365-2222.2012.03985.x. Clin Exp Allergy. 2012. PMID: 22702507 Clinical Trial.
-
Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.Drug Saf. 2017 Jun;40(6):483-495. doi: 10.1007/s40264-017-0520-7. Drug Saf. 2017. PMID: 28342074
-
Surveillance of adverse events following immunisation in Australia annual report, 2017.Commun Dis Intell (2018). 2019 Jul 16;43. doi: 10.33321/cdi.2019.43.29. Commun Dis Intell (2018). 2019. PMID: 31315166
-
Participant-centred active surveillance of adverse events following immunisation: a narrative review.Int Health. 2017 May 1;9(3):164-176. doi: 10.1093/inthealth/ihx019. Int Health. 2017. PMID: 28582563 Free PMC article. Review.
-
Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017.Rev Inst Med Trop Sao Paulo. 2018 Dec 20;61:e4. doi: 10.1590/S1678-9946201961004. Rev Inst Med Trop Sao Paulo. 2018. PMID: 30570077 Free PMC article. Review.
Cited by
-
Best vaccination practice and medically attended injection site events following deltoid intramuscular injection.Hum Vaccin Immunother. 2015;11(5):1184-91. doi: 10.1080/21645515.2015.1017694. Hum Vaccin Immunother. 2015. PMID: 25868476 Free PMC article. Review.
-
A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy.Hum Vaccin Immunother. 2016 Mar 3;12(3):651-4. doi: 10.1080/21645515.2015.1101198. Hum Vaccin Immunother. 2016. PMID: 26528829 Free PMC article.
-
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.Vaccines (Basel). 2024 Sep 20;12(9):1076. doi: 10.3390/vaccines12091076. Vaccines (Basel). 2024. PMID: 39340106 Free PMC article.
-
Vaccines for preventing influenza in healthy adults.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD001269. doi: 10.1002/14651858.CD001269.pub6. Cochrane Database Syst Rev. 2018. PMID: 29388196 Free PMC article.
-
Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.Hum Vaccin Immunother. 2015;11(1):91-4. doi: 10.4161/hv.34360. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical